IGF2BP2 and diabetic kidney disease: In conclusion, we propose the hypothesis that in HPC cells stimulated with high glucose, IGF2BP2 assists METTL3, reduces the m6A modification level of RNF183, and prevents PKM2 degradation via the RNF183 ubiquitination pathway by aggravating HPC cell dysfunction and the occurrence of diabetic nephropathy.